Workflow
塞力医疗(603716) - 2022 Q1 - 季度财报
ThalysThalys(SH:603716)2022-04-27 16:00

Financial Performance - The company's operating revenue for Q1 2022 was ¥578,884,225.92, representing a year-on-year increase of 12.01%[5] - The net profit attributable to shareholders for the same period was ¥21,185,477.22, showing a significant increase of 312.06% compared to the previous year[5] - The basic earnings per share for Q1 2022 was ¥0.10, which is an increase of 233.33% year-on-year[6] - Net profit for Q1 2022 reached CNY 25,738,000.43, representing a 84.9% increase from CNY 13,929,273.44 in Q1 2021[21] - Total operating revenue for Q1 2022 was CNY 578,884,225.92, an increase of 12.0% compared to CNY 516,817,163.09 in Q1 2021[20] - Total operating costs for Q1 2022 were CNY 540,110,563.59, up 7.8% from CNY 500,686,972.10 in Q1 2021[20] - The total comprehensive income for Q1 2022 was CNY 21,546,216.99, compared to CNY 13,200,661.86 in Q1 2021[22] Assets and Liabilities - The total assets at the end of the reporting period were ¥4,489,441,503.44, reflecting a growth of 4.56% from the end of the previous year[6] - Total liabilities as of Q1 2022 amounted to CNY 2,724,732,419.09, an increase from CNY 2,550,662,118.81 in the previous year[19] - The company reported a total non-current asset value of RMB 1,038,715,874.68, slightly down from RMB 1,051,540,970.72[17] - The total current liabilities decreased to RMB 1,200,000,000 from RMB 1,300,000,000, indicating a reduction of approximately 7.7%[16] Cash Flow - The net cash flow from operating activities was negative at -¥117,248,727.93, indicating a decrease in cash inflow from operations[5] - Cash inflow from operating activities in Q1 2022 was $459,800,471.28, a decrease of 19.3% compared to $569,643,485.49 in Q1 2021[24] - Net cash outflow from operating activities in Q1 2022 was -$117,248,727.93, compared to -$11,996,421.08 in Q1 2021, indicating a significant decline[25] - Cash inflow from investment activities in Q1 2022 totaled $12,964,949.90, down from $60,000.00 in Q1 2021[25] - Net cash outflow from investment activities in Q1 2022 was -$52,516,502.00, compared to -$40,285,175.42 in Q1 2021, reflecting increased investment expenditures[25] - Cash inflow from financing activities in Q1 2022 was $415,094,729.82, an increase from $382,481,827.88 in Q1 2021[25] - Net cash inflow from financing activities in Q1 2022 was $106,935,733.09, compared to $36,667,810.27 in Q1 2021, indicating improved financing conditions[25] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 25,492[12] - The largest shareholder, Saihai (Shanghai) Health Technology Co., Ltd., held 29.68% of the shares, amounting to 60,843,770 shares[12] Other Financial Metrics - The weighted average return on equity increased by 1.09 percentage points to 1.43%[6] - The company experienced a 93.12% decrease in trading financial assets, primarily due to the sale of wealth management products[10] - The company's cash and cash equivalents decreased to RMB 413,977,088.37 from RMB 473,549,725.12, reflecting a decline of approximately 12.6%[16] - Accounts receivable increased to RMB 1,869,356,975.69, up from RMB 1,751,902,181.52, indicating a growth of about 6.7%[16] - Other receivables rose significantly to RMB 472,971,816.65 from RMB 346,411,293.27, representing an increase of approximately 36.5%[17] - Inventory levels increased to RMB 488,002,808.59 from RMB 463,613,082.08, showing a growth of about 5.2%[17] - The company has not provided specific guidance for future performance or new product developments in the current report[15] - Research and development expenses for Q1 2022 were CNY 8,630,117.36, a decrease of 10.1% from CNY 9,603,868.15 in Q1 2021[20] - Other income for Q1 2022 was CNY 153,017.18, down significantly from CNY 2,480,390.50 in Q1 2021[20] - The company reported a credit impairment loss of CNY -3,566,099.79 in Q1 2022, compared to CNY -755,312.73 in Q1 2021[21] - Cash paid to employees in Q1 2022 was $56,812,902.26, an increase of 11.9% from $50,763,857.20 in Q1 2021[25] - Cash paid for taxes in Q1 2022 was $42,369,049.26, up from $28,588,936.47 in Q1 2021, reflecting higher tax obligations[25] - Cash paid for other operating activities in Q1 2022 was $82,395,945.86, significantly higher than $39,750,824.11 in Q1 2021, indicating increased operational costs[25]